Atlas Trials

Study To Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-999 in Healthy Young Male Volunteers

Clinical trial NCT02208934 · COMPLETED

Trial details

NCT number
NCT02208934
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Huntington's Disease
Start date
2014-09-01
Primary completion
2015-10-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.